Respiratory carePub Date : 2024-11-19DOI: 10.4187/respcare.12144
Andrew G Miller, Katlyn L Burr, John S Emberger, Carl R Hinkson, Cheryl A Hoerr, Jerin Juby, Karsten J Roberts, Brian J Smith, Shawna L Strickland, Kyle J Rehder
{"title":"Respiratory Therapy Leaders' Perceptions of Value of Respiratory Care Services.","authors":"Andrew G Miller, Katlyn L Burr, John S Emberger, Carl R Hinkson, Cheryl A Hoerr, Jerin Juby, Karsten J Roberts, Brian J Smith, Shawna L Strickland, Kyle J Rehder","doi":"10.4187/respcare.12144","DOIUrl":"https://doi.org/10.4187/respcare.12144","url":null,"abstract":"<p><strong>Background: </strong>Respiratory care departments are experiencing an increased need to demonstrate value in the care they deliver. Value efficiency is a concept that incorporates the value of individual treatments into the normal operations of a department. The purpose of this study was to describe respiratory care leaders' attitudes about the value of services provided by respiratory care departments.</p><p><strong>Methods: </strong>An electronic survey was distributed via social media, professional networks, and a manager work group. The survey was targeted to directors, managers, and supervisors of respiratory care departments. We asked questions related to value, services, and barriers to implementation of value efficiency. Data analysis was descriptive.</p><p><strong>Results: </strong>We received 116 responses; 86% were from managers or directors. The 5 most valuable services delivered were invasive mechanical ventilation (82%), noninvasive ventilation or CPAP (71%), protocol-driven care (47%), code team (44%), and rapid response team (41%). The 5 least valuable services delivered by respiratory care departments were electrocardiograms (63%), stress testing (44%), lung expansion therapies (41%), sleep studies staffed by the respiratory care department (36%), and smoking cessation education (36%). The primary barrier to value efficiency was physician prescribing practices (68%). There was general agreement that physicians support respiratory therapy protocols (71%), value should be considered when evaluating respiratory care services (95%), and directing resources to more valuable services if possible (73%). Respondents did not agree that hospital administrators understand respiratory therapy workflow and full-time equivalent needs (35%) nor that hospital administrators would be supportive if we reduced services (18%).</p><p><strong>Conclusions: </strong>In a small sample of respiratory therapy leaders, there was limited consensus on what respiratory care services are the most and least valuable. Lack of consensus on high- and low-value services and physician prescribing practice were the primary barriers to value efficiency. Nearly all respondents felt value should be considered when evaluating respiratory care services.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Respiratory carePub Date : 2024-11-19DOI: 10.4187/respcare.12341
Andrew G Miller, Jordan Pung, Karan R Kumar, Alexandre T Rotta
{"title":"Ventilation Monitoring Using a Noninvasive Bioelectrical Impedance Device in Critically Ill Children.","authors":"Andrew G Miller, Jordan Pung, Karan R Kumar, Alexandre T Rotta","doi":"10.4187/respcare.12341","DOIUrl":"https://doi.org/10.4187/respcare.12341","url":null,"abstract":"","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of Positive Expiratory Pressure Device on Gas Exchange, Atelectasis, Hemodynamics, and Dyspnea in Spontaneously Breathing Critically Ill Subjects.","authors":"Denise Masuello, Adriano Servetti, Salvatore Caiffa, Robertina Cara, Chiara Pieri, Ricardo Arriagada, Lou'i Al-Husinat, Lorenzo Ball, Chiara Robba, Iole Brunetti, Nicolò Patroniti, Pedro Leme Silva, Patricia Rm Rocco, Denise Battaglini","doi":"10.4187/respcare.12000","DOIUrl":"https://doi.org/10.4187/respcare.12000","url":null,"abstract":"<p><strong>Background: </strong>EzPAP Positive Airway Pressure System (EzPAP) is a noninvasive positive expiratory pressure (PEP) device designed to promote lung expansion. The aim of this study was to evaluate the effects of PEP on gas exchange. Secondary objectives included assessing the early effects of PEP on radiological atelectasis score (RAS), hemodynamics, and dyspnea. These outcomes were compared between spontaneously breathing subjects with and without tracheostomy.</p><p><strong>Methods: </strong>This observational single-center study was conducted at a university hospital. Inclusion criteria were spontaneously breathing adult subjects with RAS ≥ 2 and a worsened P<sub>aO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> . Exclusion criteria included life-threatening conditions, intracranial hypertension, hemodynamic instability, and pneumothorax. Gas-exchange, hemodynamic parameters, and dyspnea measured with the Respiratory Distress Observation Scale (RDOS) were assessed at 3 time points: T0 (before PEP), T1 (immediately after PEP), and T2 (2 h after PEP). RAS was assessed at T0 and 1-week post treatment (T3).</p><p><strong>Results: </strong>Of 213 patients assessed for eligibility, 186 were excluded for various reasons, leaving 27 subjects (19 without and 8 with tracheostomy) enrolled in the study. The median [interquartile range] age was 65 [58-74] y, with 66.7% being male. In the overall sample and in subjects without tracheostomy, P<sub>aO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> did not differ significantly between T1 and T0 (<i>P</i> = .52 and <i>P</i> = .54, respectively) or between T2 and T0 (<i>P</i> = .47 and <i>P</i> = .85, respectively). In subjects with tracheostomy, P<sub>aO<sub>2</sub></sub> /F<sub>IO<sub>2</sub></sub> was higher at T1 compared to T0 (<i>P</i> = .039) but not between T2 and T0 (<i>P</i> = .58). Arterial P<sub>aO<sub>2</sub></sub> and hemodynamic parameters remained unchanged in the overall cohort. The RAS improved within 1 week of treatment in the overall cohort (T3 vs T0, <i>P</i> < .001) and in subjects without tracheostomy (T3 vs T0, <i>P</i> = .001). However, PEP therapy did not improve RDOS.</p><p><strong>Conclusions: </strong>In critically ill, spontaneously breathing subjects, PEP therapy significantly improved RAS without affecting hemodynamic stability or respiratory symptoms.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Respiratory carePub Date : 2024-11-18DOI: 10.4187/respcare.12605
Luke A McDonald, Thomas C Rollinson
{"title":"Disability Following Critical Illness Due to COVID-19-Where to Next?","authors":"Luke A McDonald, Thomas C Rollinson","doi":"10.4187/respcare.12605","DOIUrl":"10.4187/respcare.12605","url":null,"abstract":"","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":"69 12","pages":"1614-1616"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Respiratory carePub Date : 2024-11-18DOI: 10.4187/respcare.11430
Linh N Tran, Jared E Rosen, Alex K Pearce, Atul Malhotra, Russell G Buhr, Ragan Saggar, Jeffrey A Davis, Jennifer L Martin, Biren B Kamdar
{"title":"Adaptive Pressure Control-Continuous Mandatory Ventilation Versus Volume Control-Continuous Mandatory Ventilation: Factors Associated With Initiation, Maintenance, and Adjustment.","authors":"Linh N Tran, Jared E Rosen, Alex K Pearce, Atul Malhotra, Russell G Buhr, Ragan Saggar, Jeffrey A Davis, Jennifer L Martin, Biren B Kamdar","doi":"10.4187/respcare.11430","DOIUrl":"10.4187/respcare.11430","url":null,"abstract":"<p><strong>Background: </strong>Adaptive pressure control-continuous mandatory ventilation (APC-CMV) is a frequently utilized ventilator mode in ICU settings. This analysis compared APC-CMV and traditional volume control-continuous mandatory ventilation (VC-CMV) mode, describing factors associated with initiation, maintenance, and changes in settings of each mode.</p><p><strong>Methods: </strong>We analyzed ventilator data from a retrospective electronic health record data set collected as part of a quality improvement project in a single academic ICU. The majority ventilator mode was defined as the mode comprising the highest proportion of mechanical ventilation time. Multivariable logistic regression was used to identify variables associated with initial and majority APC-CMV or VC-CMV modes. Wilcoxon rank-sum tests were used to compare ventilator setting changes/d and sedation as a function of APC-CMV and VC-CMV majority modes.</p><p><strong>Results: </strong>Among 1,213 subjects initiated on mechanical ventilation from January 2013-March 2017, 68% and 24% were initiated on APC-CMV and VC-CMV, respectively, which composed 62% and 21% of the majority ventilator modes. Age, sex, race, and ethnicity were not associated with the initial or majority APC-CMV or VC-CMV modes. Subjects initiated on APC-CMV spent 88% of the mechanical ventilation time on APC-CMV mode. Compared to VC-CMV, subjects with APC-CMV majority mode experienced more ventilator setting changes/d (1.1 vs 0.8, <i>P</i> < .001). There were no significant differences in sedative medications when comparing subjects receiving APC-CMV versus VC-CMV majority modes.</p><p><strong>Conclusions: </strong>APC-CMV was highly utilized in the medical ICU. Subjects on APC-CMV had more ventilator setting changes/d than those on VC-CMV. APC-CMV offered no advantage of reduced setting adjustments or less sedation compared to VC-CMV.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"1491-1498"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Respiratory carePub Date : 2024-11-18DOI: 10.4187/respcare.12450
Kristin N Sheehan, Kevin W Gibbs
{"title":"Adaptive Pressure Control Ventilation: Set It and Don't Forget It?","authors":"Kristin N Sheehan, Kevin W Gibbs","doi":"10.4187/respcare.12450","DOIUrl":"10.4187/respcare.12450","url":null,"abstract":"","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":"69 12","pages":"1607-1609"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Respiratory carePub Date : 2024-11-18DOI: 10.4187/respcare.11955
Mekenzie E Dahlin, Tara E O'Connor, Mary P Martinasek
{"title":"A Scoping Review of the Respiratory Effects of Red Tide.","authors":"Mekenzie E Dahlin, Tara E O'Connor, Mary P Martinasek","doi":"10.4187/respcare.11955","DOIUrl":"10.4187/respcare.11955","url":null,"abstract":"<p><p>Algal blooms of <i>Karenia brevis</i> produce brevetoxins that lead to the natural phenomenon of red tide. Beyond monitoring the red tide concentration and forecasting future outbreaks, uncertainty exists in the field when examining these toxins in relation to the physiology of people. Contaminated air that results from outbreaks of <i>K. brevis</i> leads to inhalation of aerosolized brevetoxins, which directly impact the human respiratory system. This scoping review focused on the respiratory effects of red tide and was conducted by using a comparative method between 2 researchers. Relevant abstracts were collected, and full-text articles were reviewed by using PubMed, Science Direct, CINAHL Complete, and BioMed Central databases. Thirty articles were included in the final analysis and categorized by study design, location, and number and age of participants, and were also divided into assessment by respiratory effects, exposure, measurements of <i>K. brevis,</i> and asthma. The research indicates that respiratory health issues exist and can be compounded with exposure to red tide, specifically upper respiratory symptoms. Both symptomatic issues and pulmonary function tests were of concern when individuals were subjected to brevetoxin exposure. Even low levels of <i>K. brevis</i> resulted in negative respiratory health effects. Red tide is common in many areas of the world. The toxins released can cause adverse respiratory effects. This article provides a comprehensive summary of the scholarly literature focused on the respiratory system and red tide produced by <i>K. brevis</i>.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"1555-1563"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142506908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Respiratory carePub Date : 2024-11-18DOI: 10.4187/respcare.12331
Rogério da Hora Passos, Igor Dovorake Lourenço
{"title":"Let It Breathe: Mastering Spontaneous Breathing Trials.","authors":"Rogério da Hora Passos, Igor Dovorake Lourenço","doi":"10.4187/respcare.12331","DOIUrl":"10.4187/respcare.12331","url":null,"abstract":"","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"1617"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142392829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Respiratory carePub Date : 2024-11-18DOI: 10.4187/respcare.11643
Xavier Muñoz, Jordi Giner, Antoni Sicras, Daniele Lo Re
{"title":"Maintenance Inhalers for Asthma and COPD in Spain.","authors":"Xavier Muñoz, Jordi Giner, Antoni Sicras, Daniele Lo Re","doi":"10.4187/respcare.11643","DOIUrl":"10.4187/respcare.11643","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to describe the use of pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs) in Spanish subjects in terms of sociodemographic, clinical, and functional characteristics in subjects with asthma or COPD on maintenance treatment with inhaled therapy.</p><p><strong>Methods: </strong>This was a retrospective, descriptive, national, multi-center, and observational study using a database with 1.8 million patients from hospitals and primary care centers as a secondary information source.</p><p><strong>Results: </strong>The sample included 24,102 subjects with asthma on maintenance therapy (26.0% with pMDI, 55% with DPI, and 19.0% with a combination of DPI + pMDI inhalers) and 12,858 subjects with COPD on maintenance therapy (26% with pMDI; 39% with DPI; and 35% with a combination of pMDI + DPI inhalers, mostly extemporary triple therapy). In proportion, subjects ≥ 75 y old used more pMDI than DPI, while younger subjects (40-64 y old) used more DPI. An inhalation chamber was prescribed in 51.0% of subjects with asthma and 47.2% of subjects with COPD treated with pMDI. The use of an inhalation chamber increases with the degree of air-flow limitation by disease and age. In subjects with comorbidities, pMDI inhaler use increased in those ≥ 75 y old for subjects with asthma and subjects with COPD. Switching from pMDI to DPI and vice versa was relatively common: 25% of subjects with asthma and 21.6% of subjects with COPD treated with pMDI had switched from DPI in the previous year. On the contrary, 14.1% and 11.4% of subjects with asthma and subjects with COPD, respectively, treated with DPI had switched from pMDI the last year.</p><p><strong>Conclusions: </strong>The use of pMDI or DPI can vary according to age, both in asthma and COPD. Switching from pMDI to DPI and vice versa is relatively common. Despite the availability of dual- and triple-therapy inhalers on the market, a considerable number of subjects were treated with multiple devices.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"1534-1542"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572995/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}